{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T15:40:25Z","timestamp":1734190825429,"version":"3.30.2"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.cyto.2024.156825","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T18:13:25Z","timestamp":1733249605000},"page":"156825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effects of probiotics on clinical manifestations and inflammatory markers in HTLV-1-associated myelopathy\/tropical spastic paraparesis: A triple blind randomized, placebo controlled trial"],"prefix":"10.1016","volume":"185","author":[{"given":"Parvaneh Mamaghani","family":"Rad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohreh","family":"Vahidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Zemorshidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Taghi","family":"Farzadfard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Khadem-Rezaiyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Boostani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Ali","family":"Nahayati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houshang","family":"Rafatpanah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariba","family":"Zemorshidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.cyto.2024.156825_bb0005","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/jnci\/87.13.1009","article-title":"Effect of human T-lymphotropic virus type I infection on non-Hodgkin\u2019s lymphoma incidence","volume":"87","author":"Cleghorn","year":"1995","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cyto.2024.156825_bb0010","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3389\/fmicb.2017.01425","article-title":"The exceptional Oncogenicity of HTLV-1","volume":"8","author":"Tagaya","year":"2017","journal-title":"Front. Microbiol."},{"issue":"12","key":"10.1016\/j.cyto.2024.156825_bb0015","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/jcp.2007.052456","article-title":"Adult T-cell leukaemia\/lymphoma","volume":"60","author":"Matutes","year":"2007","journal-title":"J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.cyto.2024.156825_bb0020","first-page":"264","article-title":"Planning and management to control and eliminate HTLV-1 infection in Iran","volume":"24","author":"Boostani","year":"2021","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"3","key":"10.1016\/j.cyto.2024.156825_bb0025","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1172\/JCI76304","article-title":"Gut\/brain axis and the microbiota","volume":"125","author":"Mayer","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.cyto.2024.156825_bb0030","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.psyneuen.2012.03.007","article-title":"Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology","volume":"37","author":"Dinan","year":"2012","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1016\/j.cyto.2024.156825_bb0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","article-title":"Gut-brain axis: how the microbiome influences anxiety and depression","volume":"36","author":"Foster","year":"2013","journal-title":"Trends Neurosci."},{"issue":"10","key":"10.1016\/j.cyto.2024.156825_bb0040","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrn3346","article-title":"Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour","volume":"13","author":"Cryan","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.cyto.2024.156825_bb0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/gbb.12109","article-title":"Microbial genes, brain & behaviour - epigenetic regulation of the gut-brain axis","volume":"13","author":"Stilling","year":"2014","journal-title":"Genes Brain Behav."},{"issue":"1","key":"10.1016\/j.cyto.2024.156825_bb0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/1756283X12459294","article-title":"Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation","volume":"6","author":"Hemarajata","year":"2013","journal-title":"Ther. Adv. Gastroenterol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156825_bb0055","article-title":"Immunomodulation of dendritic cells by Lactobacillus reuteri surface components and metabolites","volume":"9","author":"Engevik","year":"2021","journal-title":"Phys. Rep."},{"issue":"8","key":"10.1016\/j.cyto.2024.156825_bb0060","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2340\/16501977-0235","article-title":"Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy","volume":"40","author":"Paternostro-Sluga","year":"2008","journal-title":"J. Rehabil. Med."},{"key":"10.1016\/j.cyto.2024.156825_bb0065","series-title":"Interrater Reliability of a Modified Ashworth Scale of Muscle Spasticity","first-page":"415","author":"Charalambous","year":"2014"},{"issue":"Suppl. 1","key":"10.1016\/j.cyto.2024.156825_bb0070","first-page":"242","article-title":"Effect of alpha-interferon treatment on HTLV-I associated myelopathy (HAM)","volume":"39","author":"Izumo","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.cyto.2024.156825_bb0075","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00451721","article-title":"Health-related quality of life measures for women with urinary incontinence: the incontinence impact questionnaire and the urogenital distress inventory","volume":"3","author":"Shumaker","year":"1994","journal-title":"Qual. Life Res."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2024.156825_bb0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jns.2005.05.011","article-title":"A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy\/tropical spastic paraparesis","volume":"237","author":"Matsuzaki","year":"2005","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.cyto.2024.156825_bb0085","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.clnu.2016.08.015","article-title":"Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Kouchaki","year":"2017","journal-title":"Clin. Nutr."},{"issue":"4","key":"10.1016\/j.cyto.2024.156825_bb0090","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.18632\/aging.102810","article-title":"Efficacy of probiotics on cognition, and biomarkers of inflammation and oxidative stress in adults with Alzheimer\u2019s disease or mild cognitive impairment - a meta-analysis of randomized controlled trials","volume":"12","author":"Den","year":"2020","journal-title":"Aging (Albany NY)"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624003296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624003296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T15:22:07Z","timestamp":1734189727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624003296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":18,"alternative-id":["S1043466624003296"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156825","relation":{},"ISSN":["1043-4666"],"issn-type":[{"type":"print","value":"1043-4666"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of probiotics on clinical manifestations and inflammatory markers in HTLV-1-associated myelopathy\/tropical spastic paraparesis: A triple blind randomized, placebo controlled trial","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156825","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156825"}}